CIBC Asset Management
TWST icon

CIBC Asset Management’s Twist Bioscience TWST Stock Holding History

CIBC Asset Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,955
Closed -$209K – 1603
2021
Q3 		$209K Buy
1,955
+189
+11% +$21.6K ﹤0.01% 1334
2021
Q2 		$235K Hold
1,766
– – ﹤0.01% 1169
2021
Q1 		$219K Buy
+1,766
New +$268K ﹤0.01% 1182

Other funds holding TWST

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIBC Asset Management's TWST Position: Q4 2021 in Review

CIBC Asset Management sold out of Twist Bioscience (TWST) in Q4 2021, closing a stake of 1,955 shares — an estimated $209K sold.

CIBC Asset Management first reported a position in TWST in Q1 2021 and held it in 3 quarters. The position peaked at $235K in Q2 2021. 236 funds tracked by Wall St. Rank hold TWST as of Q4 2021.

  • CIBC Asset Management reported no remaining Twist Bioscience position as of Q4 2021 after selling out during the quarter.
  • CIBC Asset Management sold 1,955 Twist Bioscience shares in Q4 2021, an estimated $209K.
  • CIBC Asset Management first reported a position in Twist Bioscience in Q1 2021 and held it in 3 quarters.
  • CIBC Asset Management's Twist Bioscience position peaked at $235K in Q2 2021.
  • 236 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2021.

Based on CIBC Asset Management's 13F filing for Q4 2021, filed 8 Feb 2022.